CEPI

    OverviewSuggest Edit

    CEPI (Coalition for Epidemic Preparedness Innovations) is a company that finances and coordinates the development of vaccines against infectious diseases. It aims to find vaccines for Lassa virus, middle east respiratory syndrome (MERS), coronavirus (MERS-CoV), and Nipah virus, as well as COVID-19.

    TypePrivate
    Founded2017
    HQOslo, NO
    Websitecepi.net

    Latest Updates

    Employees (est.) (May 2022)206
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    CEPI Office Locations

    CEPI has offices in Oslo, Washington and London
    Oslo, NO (HQ)
    Marcus Thranes Gate 2
    London, GB
    215 Euston Rd, Bloomsbury
    Washington, DC, US
    1901 Pennsylvania Ave NW #1003
    Show all (3)

    CEPI Financials and Metrics

    Summary Metrics

    Founding Date

    2017

    CEPI Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    92/100

    SecurityScorecard logo

    CEPI Online and Social Media Presence

    Embed Graph

    CEPI News and Updates

    Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial

    Washington, D.C., May 17, 2022 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to evaluate the immunogenicity and safety of lower, fractional doses of registered COVID-19 vaccines us…

    CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants

    OSLO, Norway and DALLAS, April 06, 2022 (GLOBE NEWSWIRE) -- The Coalition for Epidemic Preparedness Innovations (CEPI) and Vaxxinity, Inc. (Nasdaq: VAXX), a US company pioneering the development of a new class of immunotherapeutic vaccines, today announced that they will co-fund the ongoing global…

    Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant

    EMERYVILLE, Calif. and OSLO, Norway, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, and CEPI, the Coalition for Epidemic Preparedness Innovations, today announced…

    Clover and CEPI Expand Partnership for COVID-19 Vaccine Candidate to Include Evaluation as a Booster

    CHENGDU, China and OSLO, Norway, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; Stock code: 2197.HK), a global clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates, and CEPI, the Coalition for Epidemic Preparedn…

    Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program (CORAL) Against SARS-CoV-2 Variants of Concern

    EMERYVILLE, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that the company entered into a funding agreement of up to $20.6 million with t…

    CEPI grants $14.1M to Bharat Biotech, IVI consortium to develop Chikungunya vaccine

    The consortium of Bharat Biotech and IVI will be further supported with a grant of up to $2 million from the government’s Ind-CEPI initiative.
    Show more

    CEPI Frequently Asked Questions

    • When was CEPI founded?

      CEPI was founded in 2017.

    • How many employees does CEPI have?

      CEPI has 206 employees.

    • Who are CEPI competitors?

      Competitors of CEPI include Experimur, Patient Choice Laboratories and SSS International Clinical Research.

    • Where is CEPI headquarters?

      CEPI headquarters is located at Marcus Thranes Gate 2, Oslo.

    • Where are CEPI offices?

      CEPI has offices in Oslo, Washington and London.

    • How many offices does CEPI have?

      CEPI has 3 offices.